evetiracetam versus Phenobarbitone for treatment of neonatal seizure.
Not Applicable
Completed
- Conditions
- Health Condition 1: P90- Convulsions of newborn
- Registration Number
- CTRI/2020/03/023961
- Lead Sponsor
- Dr Devdarshan Nitin Gandhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
All inborn and outborn neonates (age 0-28 days) between 35 weeks to 42 weeks of gestational age admitted in NICU with clinical seizures will be enrolled in the study.
For this study we will be considering subtle seizure, tonic seizures, clonic seizures and myoclonic seizures.
Exclusion Criteria
--Major congenital malformation
--Need for assisted ventilation at the time of admission
--Refractory shock
--Serum creatinine >2 mg/dl
--Anticonvulsant prior to admission
--Neonates with hypoglycaemia, hypocalcemia or hypo / hyperkalemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method